Interpretable Multimodal Learning for Tumor Protein-Metal Binding: Progress, Challenges, and Perspectives

• URL: http://arxiv.org/abs/2504.03847v2
• Date: Sat, 14 Jun 2025 08:13:18 GMT
• Title: Interpretable Multimodal Learning for Tumor Protein-Metal Binding: Progress, Challenges, and Perspectives
• Authors: Xiaokun Liu, Sayedmohammadreza Rastegari, Yijun Huang, Sxe Chang Cheong, Weikang Liu, Wenjie Zhao, Qihao Tian, Hongming Wang, Yingjie Guo, Shuo Zhou, Sina Tabakhi, Xianyuan Liu, Zheqing Zhu, Wei Sang, Haiping Lu,
• Abstract summary: This paper summarizes progress and ongoing challenges in using machine learning to predict tumor protein-metal binding.<n>Key challenges include a shortage of high-quality, tumor-specific datasets, insufficient consideration of multiple data modalities, and the complexity of interpreting results.<n>We propose strategies to address the scarcity of tumor protein data and the limited number of predictive models for tumor protein-metal binding.
• Score: 5.985222335965317
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: In cancer therapeutics, protein-metal binding mechanisms critically govern the pharmacokinetics and targeting efficacy of drugs, thereby fundamentally shaping the rational design of anticancer metallodrugs. While conventional laboratory methods used to study such mechanisms are often costly, low throughput, and limited in capturing dynamic biological processes, machine learning (ML) has emerged as a promising alternative. Despite increasing efforts to develop protein-metal binding datasets and ML algorithms, the application of ML in tumor protein-metal binding remains limited. Key challenges include a shortage of high-quality, tumor-specific datasets, insufficient consideration of multiple data modalities, and the complexity of interpreting results due to the ''black box'' nature of complex ML models. This paper summarizes recent progress and ongoing challenges in using ML to predict tumor protein-metal binding, focusing on data, modeling, and interpretability. We present multimodal protein-metal binding datasets and outline strategies for acquiring, curating, and preprocessing them for training ML models. Moreover, we explore the complementary value provided by different data modalities and examine methods for their integration. We also review approaches for improving model interpretability to support more trustworthy decisions in cancer research. Finally, we offer our perspective on research opportunities and propose strategies to address the scarcity of tumor protein data and the limited number of predictive models for tumor protein-metal binding. We also highlight two promising directions for effective metal-based drug design: integrating protein-protein interaction data to provide structural insights into metal-binding events and predicting structural changes in tumor proteins after metal binding.

Related papers

• Modeling Dabrafenib Response Using Multi-Omics Modality Fusion and Protein Network Embeddings Based on Graph Convolutional Networks [0.0]
  Cancer cell response to targeted therapy arises from complex molecular interactions, making single omics insufficient for accurate prediction.<n>This study develops a model to predict Dabrafenib sensitivity by integrating multiple omics layers (genomics, transcriptomics, epigenomics, metabolomics) with protein network embeddings generated using Graph Convolutional Networks (GCN)<n>Results show that attention guided multi omics fusion combined with GCN improves drug response prediction and reveals complementary molecular determinants of Dabrafenib sensitivity.
  arXiv  Detail & Related papers  (2025-12-13T02:00:56Z)
• Biologically Disentangled Multi-Omic Modeling Reveals Mechanistic Insights into Pan-Cancer Immunotherapy Resistance [0.9787436863401008]
  We introduce the Biologically Disentangled Variational Autoencoder (BDVAE), a deep generative model that integrates transcriptomic and genomic data.<n>Applying to a pan-cancer cohort of 366 patients, BDVAE accurately predicts treatment response.<n>It uncovers critical resistance mechanisms, including immune suppression, metabolic shifts, and neuronal signaling.
  arXiv  Detail & Related papers  (2025-08-26T03:33:56Z)
• impuTMAE: Multi-modal Transformer with Masked Pre-training for Missing Modalities Imputation in Cancer Survival Prediction [75.43342771863837]
  We introduce impuTMAE, a novel transformer-based end-to-end approach with an efficient multimodal pre-training strategy.<n>It learns inter- and intra-modal interactions while simultaneously imputing missing modalities by reconstructing masked patches.<n>Our model is pre-trained on heterogeneous, incomplete data and fine-tuned for glioma survival prediction using TCGA-GBM/LGG and BraTS datasets.
  arXiv  Detail & Related papers  (2025-08-08T10:01:16Z)
• Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification, An Interpretable Multi-Omics Approach [36.92842246372894]
  Multi-Omics Graph Kolmogorov-Arnold Network (MOGKAN) is a deep learning framework that utilizes messenger-RNA, micro-RNA sequences, and DNA methylation samples. By integrating multi-omics data with graph-based deep learning, our proposed approach demonstrates robust predictive performance and interpretability.
  arXiv  Detail & Related papers  (2025-03-29T02:14:05Z)
• Strategic priorities for transformative progress in advancing biology with proteomics and artificial intelligence [54.14779179869007]
  We highlight key areas where AI is driving innovation, from data analysis to new biological insights.<n>These include developing an AI-friendly ecosystem for data generation, sharing, and analysis.
  arXiv  Detail & Related papers  (2025-02-21T13:20:33Z)
• Uncertainty-Aware Adaptation of Large Language Models for Protein-Protein Interaction Analysis [10.67543730905283]
  Large Language Models (LLMs) have demonstrated remarkable potential in predicting protein structures and interactions. Yet their inherent uncertainty remains a key challenge for deriving reproducible findings. We present an uncertainty-aware adaptation of LLMs for PPI analysis, leveraging fine-tuned LLaMA-3 and BioMedGPT models.
  arXiv  Detail & Related papers  (2025-02-10T05:54:36Z)
• Computational Protein Science in the Era of Large Language Models (LLMs) [54.35488233989787]
  Computational protein science is dedicated to revealing knowledge and developing applications within the protein sequence-structure-function paradigm. Recently, Language Models (pLMs) have emerged as a milestone in AI due to their unprecedented language processing & generalization capability.
  arXiv  Detail & Related papers  (2025-01-17T16:21:18Z)
• SFM-Protein: Integrative Co-evolutionary Pre-training for Advanced Protein Sequence Representation [97.99658944212675]
  We introduce a novel pre-training strategy for protein foundation models. It emphasizes the interactions among amino acid residues to enhance the extraction of both short-range and long-range co-evolutionary features. Trained on a large-scale protein sequence dataset, our model demonstrates superior generalization ability.
  arXiv  Detail & Related papers  (2024-10-31T15:22:03Z)
• Long-context Protein Language Modeling Using Bidirectional Mamba with Shared Projection Layers [76.95505296417866]
  Self-supervised training of language models (LMs) has seen great success for protein sequences in learning meaningful representations and for generative drug design.<n>Most protein LMs are based on the Transformer architecture trained on individual proteins with short context lengths.<n>In this work, we propose LC-PLM based on an alternative protein LM architecture, BiMamba-S, built upon selective structured state-space models.
  arXiv  Detail & Related papers  (2024-10-29T16:43:28Z)
• Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches [48.66541987908136]
  Much work has been devoted to predicting binding affinity over the past decades.<n>We note growing use of both traditional machine learning and deep learning models for predicting binding affinity.<n>With improved predictive performance and the FDA's phasing out of animal testing, AI-driven in silico models, such as AI virtual cells (AIVCs), are poised to advance binding affinity prediction.
  arXiv  Detail & Related papers  (2024-09-30T03:40:49Z)
• LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification [41.94295877935867]
  This paper introduces LASSO-MOGAT, a graph-based deep learning framework that integrates messenger RNA, microRNA, and DNA methylation data to classify 31 cancer types.
  arXiv  Detail & Related papers  (2024-08-30T16:26:04Z)
• Reviewing AI's Role in Non-Muscle-Invasive Bladder Cancer Recurrence Prediction [0.4369058206183195]
  Non-muscle-invasive Bladder Cancer (NMIBC) imposes a significant human burden and is one of the costliest cancers to manage.<n>Current tools for predicting NMIBC recurrence rely on scoring systems that often overestimate risk and have poor accuracy.<n>Machine learning (ML)-based techniques have emerged as a promising approach for predicting NMIBC recurrence by leveraging molecular and clinical data.
  arXiv  Detail & Related papers  (2024-03-15T17:03:45Z)
• Efficiently Predicting Protein Stability Changes Upon Single-point Mutation with Large Language Models [51.57843608615827]
  The ability to precisely predict protein thermostability is pivotal for various subfields and applications in biochemistry. We introduce an ESM-assisted efficient approach that integrates protein sequence and structural features to predict the thermostability changes in protein upon single-point mutations.
  arXiv  Detail & Related papers  (2023-12-07T03:25:49Z)
• Functional Integrative Bayesian Analysis of High-dimensional Multiplatform Genomic Data [0.8029049649310213]
  We propose a framework called Functional Integrative Bayesian Analysis of High-dimensional Multiplatform Genomic Data (fiBAG) fiBAG allows simultaneous identification of upstream functional evidence of proteogenomic biomarkers. We demonstrate the profitability of fiBAG via a pan-cancer analysis of 14 cancer types.
  arXiv  Detail & Related papers  (2022-12-29T03:31:45Z)
• SPLDExtraTrees: Robust machine learning approach for predicting kinase inhibitor resistance [1.0674604700001966]
  We propose a robust machine learning method, SPLDExtraTrees, which can accurately predict ligand binding affinity changes upon protein mutation. The proposed method ranks training data following a specific scheme that starts with easy-to-learn samples. Experiments substantiate the capability of the proposed method for predicting kinase inhibitor resistance under three scenarios.
  arXiv  Detail & Related papers  (2021-11-15T09:07:45Z)
• Theoretical Convergence of Multi-Step Model-Agnostic Meta-Learning [63.64636047748605]
  We develop a new theoretical framework to provide convergence guarantee for the general multi-step MAML algorithm. In particular, our results suggest that an inner-stage step needs to be chosen inversely proportional to $N$ of inner-stage steps in order for $N$ MAML to have guaranteed convergence.
  arXiv  Detail & Related papers  (2020-02-18T19:17:54Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.